McKesson Q3 Earnings: Conference Call Scheduled for 4:30 PM ET

[Para 1: The Lead] McKesson Corporation (NYSE: MCK) is scheduled to hold its Q3 earnings conference call at 4:30 PM ET on February 4, 2026. Analysts anticipate a 5% increase in earnings per share to $2.15, reflecting robust performance in its pharmaceutical distribution and healthcare services segments. [Para 2-3: Supporting details & Context] The company’s financial health is bolstered by a 10% year-over-year revenue growth, driven by strong demand for its healthcare IT solutions and pharmaceutical products. McKesson’s stock (MCK) has seen a 3% rise in the past month, indicating investor confidence in the upcoming results. Market participants are expected to focus on the company’s strategies for cost management and market expansion. McKesson’s leadership team will provide an update on the company’s strategic initiatives and outlook for the fiscal year.